Praxis Precision Medicines (PRAX) Tax Provisions (2020 - 2021)
Praxis Precision Medicines' quarterly Tax Provisions came in at -$5000.0 in Q4 2021, down 200.0% quarter-over-quarter from $5000.0 in Q3 2021.
Praxis Precision Medicines has reported Tax Provisions for 2 years, with the latest figure at -$5000.0 in Q4 2021.
- For the quarter ending Q4 2021, Tax Provisions changed N/A year-over-year to -$5000.0; the trailing twelve-month figure through Sep 2021 stood at $5000.0 (changed N/A YoY), and the FY2020 full-year result was -$8000.0, up 90.48% from the prior year.
- Tax Provisions for Q4 2021 stood at -$5000.0, down from $5000.0 in the prior quarter.
- The five-year high for Tax Provisions was $5000.0 in Q3 2021, with the low at -$11000.0 in Q1 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -11.20 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -859,000.00 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 221.50 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 216,000.00 |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 104.00 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 15.66 Mn |
| 10 | Praxis Precision Medicines | 10.11 Bn | 9.32 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -5,000.00 |
| Sep 30, 2021 | 5,000.00 |
| Jun 30, 2020 | 3,000.00 |
| Mar 31, 2020 | -11,000.00 |